Quadrant Capital Group LLC Dexcom Inc Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Dexcom Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 2,924 shares of DXCM stock, worth $234,036. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,924

Previous 5,503 46.87%

Holding current value

$234,036

Previous $623,000 68.7%

% of portfolio

0.01%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$64.0 - $116.06 $165,056 - $299,318	-2,579 Reduced 46.87%	2,924 $195,000
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $13,899 - $17,696	126 Added 2.34%	5,503 $623,000
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $108,509 - $133,095	950 Added 21.46%	5,377 $745,000
Q4 2023 Feb 08, 2024	BUY	$75.49 - $124.16 $62,430 - $102,680	827 Added 22.97%	4,427 $549,000
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $31,497 - $50,482	-366 Reduced 9.23%	3,600 $335,000
Q2 2023 Aug 09, 2023	SELL	$112.47 - $130.98 $14,733 - $17,158	-131 Reduced 3.2%	3,966 $509,000
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $5,512 - $6,514	53 Added 1.31%	4,097 $475,000
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $67,304 - $97,154	792 Added 24.35%	4,044 $457,000
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $109,027 - $134,489	1,428 Added 78.29%	3,252 $262,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $83,423 - $163,056	1,227 Added 205.53%	1,824 $136,000
Q1 2022 May 06, 2022	BUY	$94.08 - $130.2 $3,386 - $4,687	36 Added 6.42%	597 $306,000
Q4 2021 Feb 01, 2022	BUY	$129.87 - $162.82 $3,766 - $4,721	29 Added 5.45%	561 $301,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $5,442 - $7,302	51 Added 10.6%	532 $291,000
Q2 2021 Aug 09, 2021	BUY	$80.99 - $107.93 $6,479 - $8,634	80 Added 19.95%	481 $205,000
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $5,511 - $6,808	65 Added 19.35%	401 $144,000
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $6,318 - $8,464	-81 Reduced 19.42%	336 $124,000
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $3,151 - $3,727	-33 Reduced 7.33%	417 $172,000
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $16,860 - $28,336	-269 Reduced 37.41%	450 $182,000
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $3,966 - $6,277	83 Added 13.05%	719 $194,000
Q4 2019 Feb 03, 2020	BUY	$36.62 - $57.29 $183 - $286	5 Added 0.79%	636 $138,000
Q1 2019 Apr 29, 2019	BUY	$28.07 - $38.18 $12,603 - $17,142	449 Added 246.7%	631 $73,000
Q4 2017 Jan 31, 2018	BUY	$11.12 - $15.38 $1,134 - $1,568	102 Added 127.5%	182 $9,000
Q3 2017 Oct 13, 2017	SELL	$11.36 - $18.98 $1,942 - $3,245	-171 Reduced 68.13%	80 $3,000
Q2 2017 Aug 15, 2017	BUY	N/A	251	251 $12,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Dexcom Inc Transaction History